Our studies show that carcinoma pathways sensitive to the expression level of talin regulate nuclear NF-kB activity suggesting that the expression levels of talin in oral carcinoma may influence the carcinoma response to cisplatin. The gene discussed is NFKB1; the disease is carcinoma.